161 related articles for article (PubMed ID: 37200388)
1. DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer.
Amer NN; Khairat R; Hammad AM; Kamel MM
PLoS One; 2023; 18(5):e0284455. PubMed ID: 37200388
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of DDX43 in lung adenocarcinoma.
Ma N; Xu HE; Luo Z; Zhou J; Zhou Y; Liu M
Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1491-1496. PubMed ID: 29044003
[TBL] [Abstract][Full Text] [Related]
3. The DEAD-box protein DDX43 (HAGE) is a dual RNA-DNA helicase and has a K-homology domain required for full nucleic acid unwinding activity.
Talwar T; Vidhyasagar V; Qing J; Guo M; Kariem A; Lu Y; Singh RS; Lukong KE; Wu Y
J Biol Chem; 2017 Jun; 292(25):10429-10443. PubMed ID: 28468824
[TBL] [Abstract][Full Text] [Related]
4. DDX43 prefers single strand substrate and its full binding activity requires physical connection of all domains.
Wu H; Zhai LT; Chen PY; Xi XG
Biochem Biophys Res Commun; 2019 Dec; 520(3):594-599. PubMed ID: 31623828
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells.
Ambrosini G; Khanin R; Carvajal RD; Schwartz GK
Mol Cancer Ther; 2014 Aug; 13(8):2073-80. PubMed ID: 24899684
[TBL] [Abstract][Full Text] [Related]
6. HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer.
Abdel-Fatah TM; McArdle SE; Johnson C; Moseley PM; Ball GR; Pockley AG; Ellis IO; Rees RC; Chan SY
Br J Cancer; 2014 May; 110(10):2450-61. PubMed ID: 24755885
[TBL] [Abstract][Full Text] [Related]
7. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
8. DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia.
Lin J; Chen Q; Yang J; Qian J; Deng ZQ; Qian W; Chen XX; Ma JC; Xiong DS; Ma YJ; An C; Tang CY
Leuk Res; 2014 May; 38(5):601-7. PubMed ID: 24656837
[TBL] [Abstract][Full Text] [Related]
9. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
Salhab M; Patani N; Jiang W; Mokbel K
Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
[TBL] [Abstract][Full Text] [Related]
10. TIMP-3 mRNA expression levels positively correlates with levels of miR-21 in in situ BC and negatively in PR positive invasive BC.
Petrovic N; Sami A; Martinovic J; Zaric M; Nakashidze I; Lukic S; Jovanovic-Cupic S
Pathol Res Pract; 2017 Oct; 213(10):1264-1270. PubMed ID: 28935174
[TBL] [Abstract][Full Text] [Related]
11. The methylation status of the DDX43 promoter in Chinese patients with chronic myeloid leukemia.
Chen Q; Lin J; Qian J; Deng ZQ; Qian W; Yang J; Li Y; Chen XX; Ma YJ; Ma JC; Liu Q
Genet Test Mol Biomarkers; 2013 Jun; 17(6):508-11. PubMed ID: 23495895
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of DEAD-box helicase DDX43.
Singh RS; Arna AB; Dong H; Yadav M; Aggarwal A; Wu Y
Methods; 2022 Aug; 204():286-299. PubMed ID: 35257897
[TBL] [Abstract][Full Text] [Related]
13. Profile of anterior gradient 3 (AGR3) mRNA expression and serum levels in benign and malignant breast tumors.
Prihantono P; Rahardjo W; Syamsu SA; Smaradhania N
Breast Dis; 2021; 40(S1):S39-S43. PubMed ID: 34057117
[TBL] [Abstract][Full Text] [Related]
14. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors.
Moazzezy N; Ebrahimi F; Sisakht MM; Yahyazadeh H; Bouzari S; Oloomi M
Asian Pac J Cancer Prev; 2016; 17(1):249-54. PubMed ID: 26838218
[TBL] [Abstract][Full Text] [Related]
15. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.
Lin Y; Zhou X; Peng W; Wu J; Wu X; Chen Y; Cui Z
BMC Cancer; 2021 Sep; 21(1):1062. PubMed ID: 34565331
[TBL] [Abstract][Full Text] [Related]
17. The melanoma-associated antigen-A3, -A4 genes: relation to the risk and clinicopathological parameters in breast cancer patients.
Hussein YM; Gharib AF; Etewa RL; El-Shal AS; Abdel-Ghany ME; Elsawy WH
Mol Cell Biochem; 2011 May; 351(1-2):261-8. PubMed ID: 21264495
[TBL] [Abstract][Full Text] [Related]
18. Loss of Dicer expression is associated with breast cancer progression and recurrence.
Khoshnaw SM; Rakha EA; Abdel-Fatah TM; Nolan CC; Hodi Z; Macmillan DR; Ellis IO; Green AR
Breast Cancer Res Treat; 2012 Sep; 135(2):403-13. PubMed ID: 22821364
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
20. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
